Bringing the fundamentals into focus…
Bringing the fundamentals into focus…
SPTX · against 467 other Healthcare companies of similar size
Ranked #428 of 468 · scores higher than 0% of peers
Bars: peers in each 10-point band of the valuation score148 peers with a valuation score of 0–9, including SPTX · Click a bar to see the companies
Mainly because of its EBITDA yield and earnings yield, which are weaker than most Healthcare peers.
| Metric | SPTX | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Earnings yieldHigher is better · 458 reported | -12.5% | 1.3% | 15% | 30% | |
| EBITDA yieldHigher is better · 473 reported | -17.7% | 4.2% | 10% | 50% | |
| Free cash flow yieldHigher is better · 201 reported | Not reported | -2.4% | — | — | 20% |
| Book yieldHigher is better · 464 reported | 39.1% | 41.2% | 47% | Context only |
A metric that is not reported is left out of the score; the other weights are rescaled.
| Rank | Company | Market cap | Valuation | Overall |
|---|---|---|---|---|
| 1 | 14.2B HKD (≈$1.8B) | 99 | 64 | |
| 1 | 12.9B HKD (≈$1.7B) | 99 | 83 | |
| 1 | 89.9B JPY (≈$611M) | 99 | 68 | |
| 1 | 226.3B JPY (≈$1.5B) | 99 | 77 | |
| 1 | 14.8B MXN (≈$800M) | 99 | 61 | |
| 428 | 1.6B USD | 0 | ||
| 428 | 1.0B EUR (≈$1.1B) | 0 | 16 | |
| 428 | 1.0B USD | 0 | 32 | |
| 428 | 1.8B AUD (≈$1.2B) | 0 | 41 | |
| 428 | 1.1B USD | 0 | ||
| 428 | 1.7B USD | 0 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score